04948632 · Active · incorporated 22 years, 11 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Healthcare Series B+
A clinical-stage biopharmaceutical company developing a first-in-class oral p300/CBP inhibitor to treat multiple myeloma and other cancers.
Cellcentric Limited is a private limited company registered at Companies House under number 04948632, incorporated on 30 October 2003, with a registered office in Cambridge. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 218 filings for this company, including 14 funding rounds. Its most recent round closed in May 2026, raising £164.9m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 14 | May 2026 | £164.9m | £3.55 |
| Round 13 | Apr 2025 | £47m | £3.51 |
| Round 12 | Jul 2024 | £49.6m | £2.61 |
| Round 11 | Aug 2023 | £2.4m | £3.12 |
| Round 10 | Jan 2022 | £15.8m | £2.60 |
| Round 9 | Oct 2020 | £10m | £2.60 |
Showing the 6 most recent of 14 rounds.
Showing the 10 most recent of 218 filings.
See the complete cap table with every shareholder, founder tags, dilution across 45 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.